Australia's Full
Federal Court this week began proceedings in an appeal of an earlier decision that upheld the validity of breast cancer diagnostic tests developed by Myriad Genetics — the same tests that were the subject of oral argument before the U.S. high court earlier this
Court this week began proceedings in an appeal of an earlier
decision that upheld the validity of breast cancer diagnostic tests developed by
Myriad Genetics — the same tests that were the subject of oral argument before the U.S. high
court earlier this
court earlier this week.